Allergy drug approved for severe chronic rhinosinusitis with nasal polyps

Study co-led by UCL and the London School of Hygiene & Tropical Medicine

First anti-BCMA therapy to be approved anywhere in the world

Roche swings and misses with another Tecentriq-chemo combo in TNBC chelfand Fri, 08/07/2020 – 03:03

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Updated Date: Thu, 30 Jul 2020 00:00:00 EDT

Creative chemists employ enzymes to build a complex but promising natural anti-cancer agent called cepafungin I in a […]